{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-005408","form_type":"8-K","ticker":"DERM","cik":"0001867066","company_name":"Journey Medical Corp","filed_at":"2023-01-20T23:59:59+00:00","discovered_at":"2026-05-14T18:03:47.265895+00:00","generated_at":"2026-06-20T12:41:31.473968+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Journey Medical CFO resigns; Corporate Controller Benesch named interim CFO effective Jan 27.","bullets":["Ernest De Paolantonio resigns as CFO effective Jan 27, 2023; will consult through March 31, 2023.","Joseph Benesch, Corporate Controller since Nov 2021, appointed interim CFO effective Jan 27, 2023.","Benesch has over 25 years of finance experience, is a CPA, and previously held senior roles at Teligent and Torrent.","No immediate change to Benesch's compensation; search for permanent CFO underway internally and externally."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-005408","json":"https://secwatch.observer/filing/0001104659-23-005408.json","markdown":"https://secwatch.observer/filing/0001104659-23-005408.md","text":"https://secwatch.observer/filing/0001104659-23-005408.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1867066/000110465923005408/0001104659-23-005408-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1867066/000110465923005408/tm234058d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-20T12:41:31.473968+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"b5db5efd91","claim":"Ernest De Paolantonio resigned as Chief Financial Officer at Journey Medical Corp.","evidence_excerpt":"On January 16, 2023, Ernest De Paolantonio, the Chief Financial Officer of Journey Medical Corporation (the “ Company ”) provided notice to the Company of his resignation, effective January 27, 2023.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1867066/000110465923005408/0001104659-23-005408-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"},{"claim_id":"d3280a9abd","claim":"Joseph Benesch was appointed as interim Chief Financial Officer at Journey Medical Corp.","evidence_excerpt":"Joseph Benesch, age 56, the Company’s Corporate Controller, was appointed as the Company’s interim Chief Financial Officer, effective January 27, 2023.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1867066/000110465923005408/0001104659-23-005408-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"interim Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}